par Suter, T.;Procter, Marion;van Veldhuisen, Dirk J;Muscholl, Michael;Carlomagno, Chiara;Perren, Thimothy J.;Passalacqua, Rodolfo;Bighin, Claudia;Klijn, J G;Ageev, Fail T;Hitre, Erika;Groetz, Juergen;Iwata, Hiroji;Knap, Malgorzata;Gnant, Michael;Muehlbauer, Susanne;Spence, Alison;Gelber, R D;Bergh, J.;Piccart-Gebhart, Martine 
Référence Journal of clinical oncology, 25, 25, page (3859-3865)
Publication Publié, 2007-09

Référence Journal of clinical oncology, 25, 25, page (3859-3865)
Publication Publié, 2007-09
Article révisé par les pairs
Titre: |
|
Auteur: | Suter, T.; Procter, Marion; van Veldhuisen, Dirk J; Muscholl, Michael; Carlomagno, Chiara; Perren, Thimothy J.; Passalacqua, Rodolfo; Bighin, Claudia; Klijn, J G; Ageev, Fail T; Hitre, Erika; Groetz, Juergen; Iwata, Hiroji; Knap, Malgorzata; Gnant, Michael; Muehlbauer, Susanne; Spence, Alison; Gelber, R D; Bergh, J.; Piccart-Gebhart, Martine |
Informations sur la publication: | Journal of clinical oncology, 25, 25, page (3859-3865) |
Statut de publication: | Publié, 2007-09 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Antibodies, Monoclonal -- administration & dosage |
Antibodies, Monoclonal -- adverse effects | |
Antineoplastic Agents -- adverse effects | |
Breast Neoplasms -- drug therapy | |
Cardiovascular Diseases -- chemically induced | |
Disease-Free Survival | |
Female | |
Heart Failure -- chemically induced | |
Humans | |
Middle Aged | |
Receptor, erbB-2 -- metabolism | |
Note générale: | Clinical Trial, Phase III |
Journal Article | |
Multicenter Study | |
Randomized Controlled Trial | |
Research Support, Non-U.S. Gov't | |
Langue: | Anglais |
Identificateurs: | urn:issn:0732-183X |
info:doi/10.1200/JCO.2006.09.1611 | |
info:pii/JCO.2006.09.1611 | |
info:pmid/17646669 |